Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 42

Sponsor: Universität des Saarlandes

Summary

The goal of this prospective interventional study is to evaluate the impact of antibiotic prophylaxis on bloodstream infections after liberation of extracorporeal membrane oxygenation therapy. The main questions aims to answer are:• does application of vancomycine prior to ECMO liberation have an impact of bloodstream infections?Participants will get 1 dose of vancomycine I.V. (15-20 mg per kgKG) prior to liberation of ECMO.Researchers will compare this interventional group to a group without antibiotic prophylaxis.

Eligibility Criteria

Inclusion Criteria:adult patients older than 18 yearsECMO-TherapyExclusion Criteria:patients younger than 18 yearsfever >38,5°Cpregnancyantibiotic treatment with Vancomycine, Linezolid, Daptomycin or Tygacil on the day of liberationprior adverse events after application of Vancomycine

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05651464). StuddyBuddy aggregates publicly available trial information.